Sector
Biotech
We tackle the unmet needs of patients
Biotech is a profoundly impactful industry. It has infinite capabilities to improve and extend lives. Nearly 20 years ago, with purpose and thoughtfulness, we embarked on advancing drug discovery and development to solve critical healthcare issues. Our disciplined and innovative approach to biotech ingenuity is serving the unmet needs of patients.
We tackle the unmet needs of patients
Biotech is a profoundly impactful industry. It has infinite capabilities to improve and extend lives. Nearly 20 years ago, with purpose and thoughtfulness, we embarked on advancing drug discovery and development to solve critical healthcare issues. Our disciplined and innovative approach to biotech ingenuity is serving the unmet needs of patients.
Science meets entrepreneurialism

Many of our investments begin with creative ideas that leverage novel scientific approaches, or proprietary IP for fueling unique solutions. We invest at all phases of a company’s lifecycle beginning with incubating a novel idea. Our world-class team of business and science experts advance entrepreneurial passion by leveraging our platforms and expertise. Our global ecosystem, mentors and supports CEOs in complex business initiatives as well as day-to-day operations, enabling numerous successful outcomes.

Revolutionizing biopharma

Preclinical cancer drug discovery, small molecule, large molecule and cell therapy are key areas of focus. Our portfolio company, BioArdis is breaking new ground in these areas. BioAtla, our Drug Discovery services platform, is revolutionizing cancer therapies with leading-edge CAB technology, achieving greater efficacy and cost efficiencies. BioDuro, one of our earliest biopharma ventures, continues to prove itself as a global leader in pharmaceutical manufacturing. It is the third largest CRDMO.

Learn more about how our Bridgewest Group empowers others.
View Bridgewest Group